{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "exchangeTimezoneName": "Asia/Taipei", "exchangeTimezoneShortName": "CST", "currency": "TWD", "market": "tw_market", "esgPopulated": false, "gmtOffSetMilliseconds": 28800000, "exchange": "TWO", "longName": "Gwo Xi Stem Cell Applied Technology Co. , Ltd", "shortName": "GWOXI", "regularMarketPrice": 55.0, "regularMarketChangePercent": 9.780443, "messageBoardId": "finmb_578360733", "marketState": "POSTPOST", "fiftyTwoWeekHighChangePercent": -0.0143369045, "fiftyTwoWeekLow": 30.8, "fiftyTwoWeekHigh": 55.8, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "fiftyTwoWeekLowChange": 24.2, "fiftyTwoWeekLowChangePercent": 0.7857143, "fiftyTwoWeekRange": "30.8 - 55.8", "fiftyTwoWeekHighChange": -0.79999924, "epsTrailingTwelveMonths": -1.29, "sharesOutstanding": 87899296, "fiftyDayAverage": 44.070835, "fiftyDayAverageChange": 10.929165, "fiftyDayAverageChangePercent": 0.24799088, "twoHundredDayAverage": 44.070835, "twoHundredDayAverageChange": 10.929165, "twoHundredDayAverageChangePercent": 0.24799088, "marketCap": 4929253888, "sourceInterval": 20, "exchangeDataDelayedBy": 20, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1682470800000, "priceHint": 2, "regularMarketChange": 4.9000015, "regularMarketTime": 1684133907, "regularMarketDayHigh": 55.8, "regularMarketDayRange": "50.4 - 55.8", "regularMarketDayLow": 50.4, "regularMarketVolume": 1980837, "regularMarketPreviousClose": 50.1, "bid": 54.7, "ask": 55.2, "fullExchangeName": "Taipei Exchange", "regularMarketOpen": 50.7, "averageDailyVolume3Month": 969663, "averageDailyVolume10Day": 851521, "symbol": "6704.TWO"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Building D", "address2": "3rd Floor No. 22, Section 2 Hsinchu County", "city": "Zhubei", "zip": "30261", "country": "Taiwan", "phone": "886 3 658 5959", "fax": "886 3 657 9922", "website": "https://www.gwoxi.com.tw", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Gwo Xi Stem Cell Applied Technology Co. , Ltd. develops stem cell medicines for patients with unmet medical needs. The company's products under development include GXHPC1, a novel autologous adipose-derived stem cell therapy in phase II clinical trials for use in the treatment of liver cirrhosis; and GXNPC1, a novel autologous adipose-derived stem cell therapy in phase II clinical trials for use in the treatment of chronic stroke. It is also developing GXCPC1, an allogeneic adipose-derived stem cells therapy in phase I/II clinical trials for use in the treatment of osteoarthritis; and GXIPC1, an allogeneic adipose-derived stem cells therapy in phase I clinical trials for use in the treatment of diabetes. The company was founded in 2011 and is based in Zhubei, Taiwan.", "companyOfficers": [], "maxAge": 86400}}], "error": null}}